Brainlab Optimizes Planning Processes and Algorithms for Cranial Indications
Brainlab, a global leader in medical technology, will showcase new Elements Cranial SRS* software at this year’s ESTRO 35, April 29-May 3 in Turin, Italy. Elements Cranial SRS offers both research and daily practice opportunities, dovetailing perfectly with ESTRO 35’s focus on multi- and interdisciplinary components in all aspects of radiosurgery treatment.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160428006094/en/
Strengthened by a new intellectual property, exclusively licensed to Brainlab, Elements Cranial SRS features a new algorithm that creates patient specific arc trajectories by penalizing geometric collisions with critical structures and rewarding steep dose gradients toward such structures.
“Working closely with our Dalhousie University partners in Halifax, Canada, we have incorporated IP technology into the next generation of Brainlab cranial software that is both innovative and powerful,” said Stefan Vilsmeier, CEO and Founder, Brainlab. “The technology bolsters our already-strong IP in beam pathway optimization. Elements Cranial SRS offers indication-specific, intelligent workflows that automate the procedure so caregivers can spend more time with patients and less time on technology.”
The new intellectual property license will help deliver patient-tailored, optimized arc trajectories aimed at minimizing radiation dose to organs at risk without compromising target coverage. The new algorithm optimizes dose delivery for selected gantry and couch positions. This optimization can be applied to fixed couch arcs as well as simultaneous gantry-couch movements. The software’s planning processes are streamlined and based on clinical need and user necessity.
“Brainlab Elements Cranial SRS is part of a suite of indication-specific and intelligent workflows for stereotactic radiosurgery,” said Claus Promberger, Director Product Portfolio, Brainlab. “Their automation and flexible business model solutions offer value to clinicians and facilities in terms of patient time and investment management.”
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 19 offices worldwide, including 320 Research & Development engineers, who form a crucial part of the product development team. Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
To learn more, visit www.brainlab.com .
*This product is not available for sale and will not be available until all applicable approvals have been obtained.
Ann Marie LaCasha
Director, Corporate Marketing
Tel: +1 708 486 1924
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IPSEN16.1.2018 23:08 | pressemeddelelse
Ipsen and Exelixis announce phase 3 trial results of cabozantinib demonstrating significant overall survival benefit in patients with previously treated advanced hepatocellular carcinoma
NY-IFF16.1.2018 22:18 | pressemeddelelse
IFF to Release Fourth Quarter & Full Year 2017 Results February 14
CA-PATIENT-SAFETY-MVMNT16.1.2018 20:19 | pressemeddelelse
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
DISARONNO16.1.2018 17:08 | pressemeddelelse
Disaronno: The Mixing Star Makes a Step Change and Looks to Innovation
NY-CHRISTIE’S16.1.2018 16:57 | pressemeddelelse
Christie’s Announces Public Preview Tour Dates for The Collection of Peggy and David Rockefeller
MA-CONTINUUM16.1.2018 16:02 | pressemeddelelse
Continuum Accelerates Global Expansion with Portland Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum